Literature DB >> 17932978

Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease.

S Din, C J Cochrane, C L Noble, J Satsangi, I D R Arnott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17932978     DOI： 10.1002/ibd.20260

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

Review 1.  Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?

Authors:  Guanglin Cui; Jon Florholmen; Rasmus Goll
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

2.  Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.

Authors:  Alan C Moss; Kyung Jo Kim; Nielsen Fernandez-Becker; Didia Cury; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2009-06-18       Impact factor: 3.199

3.  COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.

Authors:  Lev Lichtenstein; Benjamin Koslowsky; Ami Ben Ya'acov; Irit Avni-Biron; Baruch Ovadia; Ofer Ben-Bassat; Timna Naftali; Uri Kopylov; Yael Haberman; Hagar Banai Eran; Rami Eliakim; Adi Lahat-Zok; Ayal Hirsch; Eran Zittan; Nitsan Maharshak; Matti Waterman; Eran Israeli; Idan Goren; Jacob E Ollech; Henit Yanai; Bella Ungar; Benjamin Avidan; Dana Ben Hur; Bernardo Melamud; Ori Segol; Zippora Shalem; Iris Dotan; Selwyn H Odes; Shomron Ben-Horin; Yf'at Snir; Yael Milgrom; Efrat Broide; Eran Goldin; Shmuel Delgado; Yulia Ron; Nathaniel Aviv Cohen; Eran Maoz; Maya Zborovsky; Safwat Odeh; Naim Abu Freha; Eyal Shachar; Yehuda Chowers; Tal Engel; Hila Reiss-Mintz; Arie Segal; Adar Zinger; Ariella Bar-Gil Shitrit
Journal:  Vaccines (Basel)       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.